www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > Product Search > Mirabegron | 223673-61-8
english deutsch español

Suppliers for CAS

223673-61-8



 

Properties

CAS   223673-61-8 
Formula   C21H24N4O2

Structure

26 Registered suppliers


Simagchem Corporation P.R.China
Sancai Industry Co.,Ltd. P.R.China
Hangzhou Keying Chem Co., Ltd. P.R.China
H&Z Industry Co.,Ltd P.R.China
Xingrui Industry Co., Limited P.R.China
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd) P.R.China
Capot Chemical Co., Ltd. P.R.China
Leap Chem Co., Ltd P.R.China
Chemvon Biotechnology Co. Ltd. P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506
Guangzhou Topwork Chemical Co., Ltd. P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506
Hangzhou Verychem Science & Technology Co., Ltd. P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506
Arakato Development Ltd Hong Kong
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506
FUDAW INDUSTRY LTD P.R.China
Molecular Formula: C21H24N4O2S
Molecular Weight: 396.506
Wuhan PharmChem Co., LTD. P.R.China
Shandong Ench Chemical Co.,Ltd P.R.China
EINECS :800-126-3
Molecular formula :C21H24N4O2S
Shandong Minglang Chemical Co., Ltd P.R.China
EINECS :800-126-3
Molecular formula :C21H24N4O2S
Hangzhou Zhongqi Chem Co., Ltd P.R.China
EINECS :800-126-3
Molecular formula :C21H24N4O2S
EINECS :800-126-3
Molecular formula :C21H24N4O2S
Nantong Xindao Biotech Ltd P.R.China
EINECS :800-126-3
Molecular formula :C21H24N4O2S
Finetech Industry Limited P.R.China
BOC Sciences USA
Shandong SanYoung Industry Co., Ltd P.R.China
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178
More details are to be found here
AK Scientific, Inc. USA
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178
More details are to be found here
Chemos GmbH & Co. KG Germany
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178
More details are to be found here
World. Chem. Co., Ltd. P.R.China
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178
More details are to be found here
CM Fine Chemicals Switzerland
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178
More details are to be found here
Santa Cruz Biotechnology, Inc. USA
Description :
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity
  • Molecular Weight :396.51
  • Boiling Point :690.0±55.0 °C at 760 mmHg
  • Melting Point :138-145°C
  • Purity :0.99
Molecular Formula :
C21H24N4O2S
Canonical SMILES :
C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
InChI :
InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
InChIKey :
PBAPPPCECJKMCM-IBGZPJMESA-N
Appearance :
White to Off-White Solid
Application :
Adrenergic beta-3 Receptor Agonists
Storage : Store in a tightly closed container , in a cool and dry place.
Synonyms :
YM-178; YM 178; YM178
More details are to be found here

Detailed information on the suppliers of Mirabegron

Properties:

... more properties and specification on Mirabegron
© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved